YONGHE MED.GR.DL-0000025 (F:L97) — Market Cap & Net Worth
Market Cap & Net Worth: YONGHE MED.GR.DL-0000025 (L97)
YONGHE MED.GR.DL-0000025 (F:L97) has a market capitalization of $109.02 Million (€93.25 Million) as of September 16, 2026. Listed on the F stock exchange, this Germany-based company holds position #18950 globally and #1746 in its home market, demonstrating a -12.72% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying YONGHE MED.GR.DL-0000025's stock price €0.20 by its total outstanding shares 500111416 (500.11 Million). Also see balance sheet size of YONGHE MED.GR.DL-0000025 for a full breakdown of the balance sheet.
YONGHE MED.GR.DL-0000025 Market Cap History: 2021 to 2026
YONGHE MED.GR.DL-0000025's market capitalization history from 2021 to 2026. Data shows change from $945.61 Million to $116.35 Million (-37.07% CAGR). Also see how efficiently does YONGHE MED.GR.DL-0000025 generate cash for how efficiently the company converts equity into cash flow.
YONGHE MED.GR.DL-0000025 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how YONGHE MED.GR.DL-0000025's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check L97 live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.05x
YONGHE MED.GR.DL-0000025's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.35x
YONGHE MED.GR.DL-0000025's market cap is 1.35 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $945.61 Million | $2.17 Billion | $120.19 Million | 0.44x | 7.87x |
| 2022 | $795.17 Million | $1.41 Billion | -$85.86 Million | 0.56x | N/A |
| 2023 | $134.48 Million | $1.78 Billion | -$546.39 Million | 0.08x | N/A |
| 2024 | $59.64 Million | $1.80 Billion | -$226.34 Million | 0.03x | N/A |
| 2025 | $99.40 Million | $1.81 Billion | $73.71 Million | 0.05x | 1.35x |
Competitor Companies of L97 by Market Capitalization
Companies near YONGHE MED.GR.DL-0000025 in the global market cap rankings as of September 16, 2026. Review L97 tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to YONGHE MED.GR.DL-0000025 by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #288 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #911 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1001 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1234 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $423.82 |
| #911 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.39 |
| #1001 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1234 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $260.85 |
YONGHE MED.GR.DL-0000025 Historical Marketcap From 2021 to 2026
Between 2021 and today, YONGHE MED.GR.DL-0000025's market cap moved from $945.61 Million to $ 116.35 Million, with a yearly change of -37.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €116.35 Million | +17.06% |
| 2025 | €99.40 Million | +66.67% |
| 2024 | €59.64 Million | -55.65% |
| 2023 | €134.48 Million | -83.09% |
| 2022 | €795.17 Million | -15.91% |
| 2021 | €945.61 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of YONGHE MED.GR.DL-0000025 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $109.02 Million USD |
| MoneyControl | $109.02 Million USD |
| MarketWatch | $109.02 Million USD |
| marketcap.company | $109.02 Million USD |
| Reuters | $109.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About YONGHE MED.GR.DL-0000025
Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; investment and management; and wig business. The company was founded in 2005 and is headquartered in Beijing, China.